Frontlight ResearchEarly access
WithdrawnPhase 4
Reversal of Complete Heart Block With Aminophylline in Inferior Wall Myocardial Infarction Patients
Key facts
- Who runs it
- National Institute of Cardiovascular Diseases, Pakistan
- Trial code
- Status
- Withdrawn
- Phase
- Phase 4
- Started
- 19 Dec 2022
- Ended
- 17 Jan 2025
- Type of study
- Interventional
- Treatments tested
- Aminophylline Injection
- Record updated
- 25 May 2025
- Why it stopped
- we could not find patients fulfilling all of our inclusion criteria
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Adult patients admitted with recent acute inferior wall myocardial infarction (MI)
- Hemodynamically stable blood pressure
- Complete heart block with Narrow QRS < 120 ms and ventricular rate >40/min persisting for at least 6 hours, resistant to atropine
- Temporary pacemaker (TPM) already placed
- Patient asymptomatic with a mean arterial pressure of greater than 65 mmHg with TPM rate placed at 40/min
Who cannot take part
- Patients with a prior history of AV block
- Known liver disease (cirrhosis, hepatitis)
- Drugs with dromotropic effects (beta blocker, calcium channel blocker, inotropes)
- Patients with cardiogenic shock
- Patients with preexisting permanent pacemaker and Implantable Cardioverter Defibrillator (ICD)
- Hypothyroidism
- Unable to consent
About the trial
What the trial wants to find out
In this study, the investigator will evaluate the rate of reversal of complete heart block with aminophylline in atropine resistant patients with inferior wall myocardial infarction (MI)
The group in the trial
- Treatment groupTreatment being tested
Patients receiving Injection Aminophylline
Treatment: Aminophylline Injection
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Assessing the Impact of Aminophylline in the Reversal of Complete Heart Block Secondary to Inferior Wall MI in Atropine Resistant Patients: An Open Label Non-randomized Clinical Trial
- Record updated
- 25 May 2025